32
Participants
Start Date
February 8, 2019
Primary Completion Date
August 30, 2019
Study Completion Date
August 30, 2019
Caffeine
The 160 mg caffeine pulsatile-release formulation was manufactured using a drug layering process. Caffeine and the excipients are dispersed in the coating media and then sprayed onto inert microcrystalline cellulose spheres using a fluid bed through a Wurster tube with continuous inlet air that dries the liquid in the dispersion, to obtain various layers consisting of caffeine and release-controlling polymers. The applied release-controlling polymeric system is based on methacrylate copolymers, which control the release of caffeine in pH-dependent and pH-independent manner. The release mechanism of the polymeric system is mainly driven by the swellability and permeability of the copolymers. The final micropellets are then encapsulated into hydroxypropylmethylcellulose capsules.
Placebo
Identical hydroxypropylmethylcellulose capsules without containing caffeine micropellets.
University of Zurich, Zurich
Collaborators (1)
Lokman Hekim University
OTHER_GOV
Elixir Pharmaceuticals
INDUSTRY
University of Zurich
OTHER